(Date:11/19/2008)...o flying creatures like hummingbirds and bats, man...orms of fluid flow. When the 61st Annual Meeting o...Fluid Dynamics takes place from November 23-25 at ...m across the globe will describe cutting-edge rese...alternative energy, biology, and medicine. , Re...
(Date:11/19/2008)...se patterns and increasing pressures on water reso... Traditional stormwater management focuses on regu...lly does little to restore the hydrologic cycle di...soils with low permeability. The lack of infiltrat... has negative repercussions on water quality downs...
(Date:11/19/2008)...gie Mellon University,s Robotics Institute have re....S. Department of Agriculture (USDA) to build auto...d one is for orange growers, but both are designed...ts. , The systems use sensors on autonomous robo... to gather a multitude of data about tree health a...
(Date:11/19/2008)...researchers led by investigators at the Albert Ein...s determined that certain commonly-prescribed medi...reasing the frequency of migraine attacks. This im...ibe migraine medicines. , In a recent article pu...d study of more than 8,000 migraine sufferers nati...
Breaking Biology News(10 mins):Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 2Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 3Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 4Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 5Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 6Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 7Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25 8Urban trees enhance water infiltration 2Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 2Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 3Overuse of narcotics and barbiturates may make migraine worse 2Rosetta Genomics Reports First Quarter 2008 Financial Results 5550 1Rosetta Genomics Reports First Quarter 2008 Financial Results 5550 2Rosetta Genomics Reports First Quarter 2008 Financial Results 5550 3Rosetta Genomics Reports First Quarter 2008 Financial Results 5550 4Rosetta Genomics Reports First Quarter 2008 Financial Results 5550 5Rosetta Genomics Reports First Quarter 2008 Financial Results 5550 6Rosetta Genomics Reports First Quarter 2008 Financial Results 5550 7Rosetta Genomics Reports First Quarter 2008 Financial Results 5550 8Rosetta Genomics Reports First Quarter 2008 Financial Results 5550 9Rosetta Genomics Reports First Quarter 2008 Financial Results 5550 10Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin 28SNS 595 29 in Acute Myeloid Leukemia 2162 1Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin 28SNS 595 29 in Acute Myeloid Leukemia 2162 2Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin 28SNS 595 29 in Acute Myeloid Leukemia 2162 3Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin 28SNS 595 29 in Acute Myeloid Leukemia 2162 4Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin 28SNS 595 29 in Acute Myeloid Leukemia 2162 5Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology 28PCT 29 at Scientific Symposia in Philade 2159 1Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology 28PCT 29 at Scientific Symposia in Philade 2159 2Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology 28PCT 29 at Scientific Symposia in Philade 2159 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology 28PCT 29 at Scientific Symposia in Philade 2159 4Simple Case Management Cuts Pulmonary Disease Admissions 19979 1Simple Case Management Cuts Pulmonary Disease Admissions 19979 2(Date:11/20/2008)...swire-FirstCall/ -- Transgenomic,(OTC Bulletin Bo...d a Phase I,Small Business Innovation Research (S...F) to support the development of its proposed SURV...) technology. A cost-effective and,high throughpu...EAL will,identify DNA variations between a refere...
(Date:11/20/2008)...ewswire/ -- WWMR, Inc., the marketing research,le...l "Most Appreciated Pain,Drug Company Survey". T...,Eli Lilly and Endo Pharmaceuticals, according t...ember 2008. These companies are most noted for,t...representatives, their,sampling/voucher plans, an...
(Date:11/20/2008)...PRNewswire-FirstCall/ -- Duska Therapeutics,Inc....ence call today at,2:30 p.m. EST to review its dr... the third quarter of 2008. Duska,s chief executiv...all and there will be a question-and-answer sessio...in the teleconference, please call toll-free 800.8...
(Date:11/20/2008)...wswire-FirstCall/ -- SPO Medical Inc. (OTC:,SPOM ...oprocessor,technologies for use in portable monit...-month period ended September 30, 2008. , D...onomic environment,gross revenues for the nine m...were mainly due to the lower sales in the US homec...
Breaking Biology Technology:Transgenomic Awarded SBIR Grant to Support Development of SURVEYOR(R) Endonuclease Adaptor-ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation 2Transgenomic Awarded SBIR Grant to Support Development of SURVEYOR(R) Endonuclease Adaptor-ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation 3WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals 2WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals 3Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 2Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 3Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 4Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 5Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 6Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 7SPO Medical Reports Nine Month Period Ending September 2008 2SPO Medical Reports Nine Month Period Ending September 2008 3...ion digital mammography system, described as a bre...ved approval from the United States Food and Drug ... that the medical community is moving to adopt dig...images for the detection of breast cancer. With a ...said the Senographe Essential system offers the la...
...nology Network, we asked William Yasnoff, founder ... foster the adoption of electronic health records ...art 1 of this interview. , , William Yasnoff ...nference 2006 , where he will deliver a presentati...pproach to Health Information Infrastructure." , ...
...y Council , a policy advisor to the governor and t... announced eight additions to its board of directo...ill join a board that includes more than three doz...mmunity. Electees include four technology organiza...O of Virent Energy Systems , , Neil Bretl, preside...
...y three of the 35 Midwestern venture capital deals...e local observer isn\,t alarmed. , ,A MoneyTree ...nies attracted a total of $185 million during the ...h at least $7 million. Given the state\,s historic...view this as the continuation of an ominous trend....
Other Biology Technology:FDA approves advanced digital mammography system 2Interview: Dr. William Yasnoff on health records, part 2 2Interview: Dr. William Yasnoff on health records, part 2 3Interview: Dr. William Yasnoff on health records, part 2 4Interview: Dr. William Yasnoff on health records, part 2 5Interview: Dr. William Yasnoff on health records, part 2 6Angel investing should lead to more venture funding, Ward says 2Angel investing should lead to more venture funding, Ward says 3Agarose-LE, 500 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals .
Request Info
Request Info
FITC~Bovine Serum Albumin
Biology Products: